Some breast cancer survivors may have a slightly reduced risk for Alzheimer’s disease, though the benefit appears to be ...

Yiviva, a clinical-stage biotechnology company pioneering systems biology-driven therapeutics, announced data from its ...

On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at ASCO 2025 – LOS ANGELES, CA, July 07, ...

National Footprint of NEXICART-2 Trial Sites Expanded - - On track for first Biologics License Application (BLA) approved ...

Dr. Wang receives compensation as a member of SELLAS’s Scientific Advisory Board, and this financial relationship has been disclosed to MD Anderson’s Conflict of Interest Committee in accordance with ...

Jamaica Hospital Medical Center is seeking state approval to start construction for a new six-story cancer facility as part ...